ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,324,820 | +4.7% | 67,544 | -0.2% | 0.01% | +16.7% |
| Q2 2023 | $6,041,600 | -16.8% | 67,693 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $7,258,044 | -12.2% | 67,693 | 0.0% | 0.02% | -15.8% |
| Q4 2022 | $8,267,346 | +247.5% | 67,693 | +193.8% | 0.02% | +216.7% |
| Q3 2022 | $2,379,000 | +11.1% | 23,043 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $2,142,000 | +8.6% | 23,043 | +37.1% | 0.01% | +25.0% |
| Q1 2022 | $1,972,000 | -27.7% | 16,806 | -17.1% | 0.00% | -20.0% |
| Q4 2021 | $2,728,000 | -3.2% | 20,281 | +14.7% | 0.01% | -16.7% |
| Q3 2021 | $2,819,000 | -25.3% | 17,685 | -38.3% | 0.01% | -25.0% |
| Q2 2021 | $3,774,000 | -56.2% | 28,685 | -57.1% | 0.01% | -57.9% |
| Q1 2021 | $8,620,000 | +34.8% | 66,882 | +74.4% | 0.02% | +26.7% |
| Q4 2020 | $6,395,000 | -18.8% | 38,345 | -24.9% | 0.02% | -25.0% |
| Q3 2020 | $7,876,000 | +16.6% | 51,040 | +11.8% | 0.02% | +11.1% |
| Q2 2020 | $6,755,000 | +39.6% | 45,669 | +6.3% | 0.02% | +12.5% |
| Q1 2020 | $4,838,000 | -29.5% | 42,958 | -12.9% | 0.02% | -11.1% |
| Q4 2019 | $6,861,000 | – | 49,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |